General Information
Version
2.2
Revision date
2023-11-01
Product name
Cellflo6
Product Synonyms
Not Available
Chemical name
Not Applicable
1.2.1 Relevant identified uses
Therapeutic or pharmacologically-active agent
Icons in SDS
Company Information
company name
Cambridge Commodities
e-mail address of the competent person responsible for the Safety Data Sheet
enquiries@cambridgecommodities.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H361fd
Hazard statements
Code
Statements
H361fd
Suspected of damaging fertility; Suspected of damaging the unborn child
Section 2
SECTION 2: Hazards identification
Regulation, UK SI 2019/720, and UK SI 2020/1567 Classification of the substance or mixture Classified according to GB-CLP Regulation, UK SI 2019/720 and UK SI H361fd - Reproductive Toxicity Category 2 2020/1567 [1] Legend Classified by Chemwatch; 2. Classification drawn from GB-CLP Regulation, UK SI 2019/720 and UK SI 2020/1567
Signal word
Warning
Hazard statements
H361fd Suspected of damaging fertility. Suspected of damaging the unborn child.
Supplemental label elements
Not Applicable
Prevention
P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/protective clothing/eye protection/face protection.
Response
P308+P313 IF exposed or concerned: Get medical advice/ attention.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/container to authorised hazardous or special waste collection point in accordance with any local regulation. Material contains epigallocatechin gallate, caffeine.
2.3 Other hazards
Skin contact and/or ingestion may produce health damage*. Cumulative effects may result following exposure*. May produce skin discomfort*. Limited evidence of a carcinogenic effect*. Possible respiratory and skin sensitizer*. *LIMITED EVIDENCE REACH - Art.57-59: The mixture does not contain Substances of Very High Concern (SVHC) at the SDS print date. This substance/mixture does not meet the criteria for classification as Persistent, Bioaccumulative, and Toxic (PBT) in accordance with Annex XIII, Commission Delegated Regulation (EU) 2017/2100, and Commission Regulation (EU) 2018/605. This substance/mixture does not meet the criteria for classification as very Persistent and very Bioaccumulative (vPvB) in accordance with Annex XIII, Commission Delegated Regulation (EU) 2017/2100, and Commission Regulation (EU) 2018/605. This substance/mixture does not meet the criteria for classification as Persistent, Mobile and Toxic (PMT) in accordance with Commission Delegated Regulation (EU) 2023/707. This substance/mixture does not meet the criteria for classification as very Persistent and very Mobile (vPvM) in accordance with Commission Delegated Regulation (EU) 2023/707. The substance/mixture does not contain components considered to have endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605, nor is it included in the list established under REACH Article 59(1), at concentrations equal to or greater than 0.1% (w/w). No further product hazard information.
2.1 Classification of the substance or mixture
Classified according to GB-CLP Regulation, UK SI 2019/720 and UK SI H361fd - Reproductive Toxicity Category 2 2020/1567 [1] Legend: 1. Classified by Chemwatch; 2. Classification drawn from GB-CLP Regulation, UK SI 2019/720 and UK SI 2020/1567